Projects per year
Personal profile
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Marco Pravetoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Summer Research Program for Diversity Students in PharmacoNeuroImmunology
Molitor, T. W., Carroll, D. M., Gewirtz, J. C., Hatsukami, D. K. & Pravetoni, M.
7/1/21 → 5/31/26
Project: Research project
-
Adjuvanted Opioid Vaccine for Treating Fentanyl Use Disorder
Pravetoni, M. & Borgatti, A. M.
9/30/20 → 9/29/21
Project: Research project
-
-
Antibody-based countermeasures against fentanyl and its analogues
9/1/20 → 7/31/23
Project: Research project
-
Novel nanovaccines against opioid use disorder
Pravetoni, M. & Birnbaum, A. K.
VIRGINIA POLYTECHNIC INST. & STATE UNIV.
7/15/19 → 6/30/22
Project: Research project
-
Contribution of antibody-mediated effector functions to the mechanism of efficacy of vaccines for opioid use disorders
Kelcher, A. M. H., Baehr, C. A., Hamid, F. A., Hart, G. T. & Pravetoni, M., Aug 1 2021, In: Journal of Immunology. 207, 3, p. 860-867 8 p.Research output: Contribution to journal › Article › peer-review
-
Countermeasures for Preventing and Treating Opioid Overdose
France, C. P., Ahern, G. P., Averick, S., Disney, A., Enright, H. A., Esmaeli-Azad, B., Federico, A., Gerak, L. R., Husbands, S. M., Kolber, B., Lau, E. Y., Lao, V., Maguire, D. R., Malfatti, M. A., Martinez, G., Mayer, B. P., Pravetoni, M., Sahibzada, N., Skolnick, P., Snyder, E. Y. & 3 others, , Mar 2021, In: Clinical pharmacology and therapeutics. 109, 3, p. 578-590 13 p.Research output: Contribution to journal › Review article › peer-review
-
Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge
Stone, A. E., Scheuermann, S. E., Haile, C. N., Cuny, G. D., Velasquez, M. L., Linhuber, J. P., Duddupudi, A. L., Vigliaturo, J. R., Pravetoni, M., Kosten, T. A., Kosten, T. R. & Norton, E. B., Dec 2021, In: npj Vaccines. 6, 1, 69.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder
Raleigh, M. D., King, S. J., Baruffaldi, F., Saykao, A., Hamid, F. A., Winston, S., LeSage, M. G., Pentel, P. R. & Pravetoni, M., Sep 1 2021, In: Neuropharmacology. 195, 108653.Research output: Contribution to journal › Article › peer-review
-
Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity
Raleigh, M. D., Accetturo, C. & Pravetoni, M., Sep 1 2020, In: Journal of Pharmacology and Experimental Therapeutics. 374, 3, p. 392-403 12 p.Research output: Contribution to journal › Article › peer-review
Press / Media
-
U of M researchers receive $2.4 million grant to develop fentanyl vaccines and antibodies
10/7/20
1 item of Media coverage
Press/Media: Research
-
U of M researchers working to develop vaccine for future coronavirus strains
Marco Pravetoni & Geoffrey T Hart
7/15/20
1 item of Media coverage
Press/Media: Expert Comment